The company is substantially boosted this progress of an novel therapy for ATTR-CM, employing the investigational drug. Preliminary trial data reveals promising improvements for patients suffering from this debilitating https://bridgebio623299.pages10.com/firm-advances-attr-cm-treatment-with-the-therapy-77580242